Some clinical and laboratory features in 183 RA patients at inclusion in the prospective study. Mean disease duration at inclusion was 11 months. The data are also displayed separately for deceased and surviving patients, respectively. Values are given as median (interquartile range)
| All patients (n=183) | Dead at follow up (n=18) | Alive at follow up (n=165) | |
|---|---|---|---|
| Active joint count (0–50) | 6 (4–10) | 9 (4–11) | 6 (3–10) |
| HAQ disability index (0–3) | 0.8 (0.5–1.3) | 1.0 (0.5–1.4) | 0.8 (0.5–1.2) |
| Joint damage score (0–200) | 6 (3–11) | 11 (6–23) | 7 (3–11) |
| ESR (mm/h) | 29 (14.5–52) | 25 (14–39) | 29 (14–56) |